共 50 条
- [5] BIOAVAILABILITY OF TOTAL AND UNBOUND DISOPYRAMIDE - IMPLICATIONS FOR CLINICAL USE OF THE IMMEDIATE AND CONTROLLED-RELEASE DOSAGE FORMS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (08): : 823 - 828
- [6] Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (12):
- [7] Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):
- [8] Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
- [9] CLINICAL PHARMACOKINETICS OF CONTROLLED-RELEASE DISOPYRAMIDE IN PATIENTS WITH CARDIAC-ARRHYTHMIAS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (04): : 306 - 311